Quantitative evaluation of 99mTc-pyrophosphate SPECT/CT in the diagnosis of transthyretin amyloid cardiomyopathy
Conclusions: A novel three-dimensional quantitative assessment of PYP SPECT/CT could accurately differentiate ATTR-CM patients from non-ATTR-CM patients, which should be studied in a larger prospective manner.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Watanabe, S., Yoneyama, H., Nakajima, K., Wakabayashi, H., Inaki, A., Komatsu, J., Yoshida, S., Konishi, T., Kinuya, S. Tags: Clinical Science (Poster Session) Source Type: research
More News: Amyloidosis | Cardiology | Cardiomyopathy | Genetics | Heart | Nuclear Medicine | Sarcoidosis | Science | SPECT | Study